
Sign up to save your podcasts
Or


Interview with Dr. Matthew Wall. He is a neuroscientist, psychologist, and fMRI (brain imaging) specialist with Imperial College London and Invicro (a CRO focused on medical imaging). His research has explored the domains of neuropsychopharmacology, addiction, psychedelics, cannabis, sex hormones, pain, weight loss, and much more. We discuss Dr. Wall’s journey into the field, his recent projects, innovations in fMRI & medical imaging, how AI is going to change everything, and the future of neurotech. Recorded January 11, 2024. Host: Robert
Key Moments
0:00 Intro
3:56 What are you working on now? (Sex, Cannabis, Psychedelics, and more)
15:26 Scientific Theories Behind Psychedelic Applications in Mental Health
19:18 FDA and Psychedelics
20:36 Innovations in fMRI Imaging Over the Years
24:50 Contribution of AI to fMRI and Neuroimaging Innovation
26:53 Background on Data Streams an fMRI Scanner Provides
29:14 PETxfMRI & EEGxfMRI
32:25 fMRI Brain-Computer Interfaces
35:16 Related modalities: fNIRS, MEG
36:12 Minimizing fMRI and why its so large
37:49 Bedside fMRI
38:11 Predictions for the Future of Neurotech and fMRI
45:21 Conclusion and Contact Information
Links
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
Dr. Wall’s Link Tree: https://linktr.ee/mbwall
Interview with Michael Byrne, the CEO and Co-Founder of sleep-focused neurotech startup, Bia Neuroscience. We discuss the importance of sleep, Michael’s journey into the realm of sleep technology, Bia’s product and differentiation, finding technical co-founders, team building as a business focused executive, aligning business/technical strategies, the future of neurotech, advice for young people looking to break into the space, and more! Recorded March 20, 2024. Host: Robert Murcko
Key Moments
0:00 Intro
4:38 Initial Interest in Neuroscience and Neurotechnology
5:50 Interest in Sleep
7:45 Founding Story of Bia Neuroscience
9:57 Bia’s Product: Capabilities and Customer Fit
12:31 Audio Component of Bia’s Product
14:10 Bia Neuroscience’s Competitors and Market Landscape
15:51 Finding Technical and Scientific Co-Founders
17:44 Finding Technical Staff
20:24 Skills and Mindsets for Being an Operator in a Technical Space
23:05 Ego (Don’t Be Scared to Ask “Dumb Questions”)
24:10 Aligning Business Strategy with Technical Goals
28:20 Day-to-Day for a Neurotech Executive
31:11 Advice for Breaking into Neurotech
33:11 Advice for Neuroscience or Neurotech Co-Founders
35:32 Future of Neurotechnology
38:18 Content Recommendations
39:41 Conclusion and Contact Info
Links
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
Bia Neuroscience Website: https://getbia.com/
Michael Byrne’s LinkedIn: https://www.linkedin.com/in/michael-kp-byrne/
Michael Byrne’s E-Mail: [email protected]
Interview with Caitlin Baltzer, the CEO and Co-Founder of neuroimaging and brain analytics startup, MYndspan. She shares some details about Magnetoencephalography (MEG), the modality her startup uses for neuroimaging. She also gives us the story behind MYndspan’s founding and how she ended up where she is today. You’ll see some clues about what’s next for MYndspan and a short conversation about the future of neurotech at large. Recorded March 18, 2024. Host: Robert Murcko
Key Moments:
0:00 Intro
4:50 Initial Interest in Neuroscience and Neurotechnology
6:43 MYndspan Founding and Timeline
10:20 Imaging and Report Generation Process (User Experience)
12:14 Idea for MYndspan: Eureka Moment or Slow Buildup
13:56 Brain Analytics
17:02 Magnetoencephalography (MEG) Explanation
20:18 MYndspan’s Key Product
23:31 Direct-to-Consumer (D2C) Framework
24:11 MYndspan’s Locations
25:08 CEO with Banking and Strategy Background
26:30 Topics Caitlin is Passionate About
27:32 Transition from COO to CEO
29:42 Day-to-Day for a CEO
31:02 A Rising Tide Lifts All Boats
32:36 MYndspan’s Differentiation and Competitors
34:40 What’s next for MYndspan
36:23 Advice: You Don’t Need a Perfect Plan
38:30 Future of Neurotechnology
41:49 Conclusion and Contact Info
Links
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
MYndspan Website: https://myndspan.com/
Interview with Dr. Avinash Singh. He is a professor at the University of Technology, Sydney working on Neuroadaptive brain-computer interfaces, neuroethics, and standardization in the space of
Key Moments:
0:00 Intro
2:16 Initial Interest in Neurotechnology
5:03 Dr. Warwick’s Early Brain-Computer Interface
6:17 Transition into Neurotech
9:37 Standardization in the BCI Research
16:56 Neuro-Adaptive BCIs
23:21 Neural Signature of Prediction Error
26:30 Machine Learning (Reinforcement Learning with Human Feedback) for Neuro-Adaptive BCIs
33:32 Neuroethics
41:23 Transhumanism
49:02 Future of Neurotechnology
55:58 Conclusion and Contact Info
Links
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
Dr. Singh UT Sydney Profile: https://profiles.uts.edu.au/Avinash.Singh
Dr. Singh LinkedIn: https://www.linkedin.com/in/avinashks/
Interview with Dr. Christoph Guger, the CEO of g.tec Medical Engineering and an innovator in the field of neurotechnology and BCI. We have a wide ranging discussion spanning from his personal journey to get to where he is today, specifics about his company, the early days of neurotechnology, the future of neurotechnology, and more! Recorded January 24, 2024. Host: Robert Murcko
Key Moments:
0:00 Intro
2:21 Initial Interest in Neurotechnology
3:28 Background on g.tec
8:11 RecoveriX
14:03 EEG Biomarker of Neuroplasticity
15:55 g.tec Brain Computer Interface System (g.bcisys)
19:25 Recording physiological and pathological cortical activity and exogenous electric fields using graphene microtransistor arrays in vitro
23:50 g.tec’s Educational and Community Initiatives in the Neurotechnology Space (BCI Award, Spring School, etc.)
29:19 What is next for g.tec?
31:59 Advice for students or young professionals looking to work in neurotech
34:09 Predictions for the Future of Neurotech (next 20 years)
36:27 Closing Remarks and Dr. Guger’s Contact Info
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
gtec website: https://www.gtec.at/
Interview with Dr. Marijin Lijffijt who is a neuropsychopharmacologist by training and now works as a consultant for various biotech and pharma start-ups. We talk about his transition from being a PI in academia to the start-up world, some of the projects related to EEG biomarkers that he is currently working on, how relatively little the world knows about mental health disorders, paths to finding out more about these disorders (which may lead to better treatments and identification), the future of neurotech, and more! Recently he has worked with Sage Therapeutics and Sama Therapeutics. Recorded January 2, 2024. Host: Robert Murcko
Key Moments:
0:00 Intro
5:50 Transition from Academia Into Startups
13:00 Dr. Lijffijt’s projects with Sama Therapeutics
24:18 Brief discussion about AI and machine learning and how they are revolutionizing the field of biotech
26:09 Predictions for the future of neurotech
33:51 Closing remarks and Dr. Lijffijt’s contact information
Links
Free Neurotech Newsletter: https://neurotechnologynews.beehiiv.com/subscribe
Dr. Marijin Lijffijt’s LinkedIn: https://www.linkedin.com/in/cns-treatment-innovation/
Sama Therapeutics: https://sama.ac/
Interview with Dr. Paul Le Floch. We talk about his journey thus far, his start-up (Axoft), clinical translation, the current neurotech landscape, the future of neurotech, and more. Recorded: January 15, 2024. Co-hosts: Robert Murcko and Yuqing Wang. [Subscribe to free neurotech newsletter: https://neurotechnologynews.beehiiv.com/subscribe]. [Axoft Website: https://axoft.us/]
From the publisher's feed